Cancer-associated fibroblast-derived exosomal microRNA-98-5p promotes cisplatin resistance in ovarian cancer by targeting CDKN1A

Hua Guo,Chunfang Ha,Hui Dong,Zhijuan Yang,Yuan Ma,Yonghui Ding

DOI: https://doi.org/10.1186/s12935-019-1051-3

IF: 6.429

2019-12-01

Cancer Cell International

Abstract:Abstract Background Ovarian cancer (OC) is a gynecological malignancy with a high mortality. Cisplatin-based treatment is the typical treatment regimen for OC patients; however, it may cause unfavorable resistance. The current study intends to explore the function of cancer-associated fibroblast (CAF)-derived exosomal microRNA-98-5p (miR-98-5p) in cisplatin resistance in OC, and the participation of CDKN1A. Methods Bioinformatics analysis was employed in order to obtain cisplatin resistance-related differential genes in OC as well as possible upstream regulatory miRs. After gain- and loss-of-function assays in OC cells, RT-qPCR and western blot analysis were employed to measure CDKN1A and miR-98-5p expression. Dual luciferase reporter assay was applied to verify the targeting relationship between miR-98-5p and CDKN1A. CAFs were treated with miR-98-5p inhibitor, and then exosomes were isolated and co-cultured with OC cells. CCK-8, colony formation and flow cytometry assays were conducted to assess cell proliferation, cell colony formation, cell cycle distribution and cell apoptosis, respectively. At last, xenograft tumor in nude mice was carried out to test whether exosomal miR-98-5p could affect cisplatin resistance in OC in vivo. Results CDKN1A was highly expressed in cisplatin-sensitive OC cell lines, and silencing CDKN1A significantly promoted proliferation and cell cycle entry but decreased apoptosis in cisplatin-sensitive OC cells. miR-98-5p targeted CDKN1A to inhibit CDKN1A expression. CAF-derived exosomal miR-98-5p increased OC cell proliferation and cell cycle entry, but suppressed cell apoptosis. Furthermore, exosomal miR-98-5p promoted cisplatin resistance and downregulated CDKN1A in nude mice. Conclusion Collectively, CAF-derived exosomes carrying overexpressed miR-98-5p promote cisplatin resistance in OC by downregulating CDKN1A.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the mechanism of cisplatin resistance in ovarian cancer (OC). Specifically, the study aims to explore the role of exosomal microRNA - 98 - 5p (miR - 98 - 5p) derived from cancer - associated fibroblasts (CAFs) in cisplatin resistance of ovarian cancer and its relationship with CDKN1A. Through this study, the authors hope to reveal the molecular mechanism by which CAFs affect the sensitivity of ovarian cancer cells to cisplatin through the transfer of miR - 98 - 5p by exosomes, thereby providing new treatment strategies for overcoming cisplatin resistance in ovarian cancer.

### Research Background
Ovarian cancer is a gynecological malignant tumor with a high mortality rate, and cisplatin is one of the standard drugs for treating ovarian cancer. However, long - term use of cisplatin can lead to drug resistance in tumor cells, which seriously affects the treatment effect. Cancer - associated fibroblasts (CAFs) play an important role in various cancers, especially in promoting tumor progression and drug tolerance. Studies have shown that CAFs can affect the behavior of tumor cells by secreting exosomes.

### Research Objectives
1. **Explore the role of exosomal miR - 98 - 5p derived from CAFs in cisplatin resistance of ovarian cancer**: Verify through experiments whether exosomal miR - 98 - 5p derived from CAFs can promote the cisplatin resistance of ovarian cancer cells.
2. **Explore the relationship between miR - 98 - 5p and CDKN1A**: Verify whether miR - 98 - 5p inhibits its expression by targeting CDKN1A, thereby affecting cisplatin resistance.

### Research Methods
- **Bioinformatics analysis**: Screen for differentially expressed genes related to cisplatin resistance and possible upstream regulatory miRNAs.
- **Gain - and - loss - of - function experiments**: Observe the impact on ovarian cancer cells by transfecting miR - 98 - 5p mimics or inhibitors.
- **RT - qPCR and Western Blot**: Detect the expression levels of CDKN1A and miR - 98 - 5p.
- **Dual - luciferase reporter gene assay**: Verify the targeting relationship between miR - 98 - 5p and CDKN1A.
- **Cell proliferation, colony formation, cell cycle and apoptosis detection**: Evaluate the impact of miR - 98 - 5p on the biological behavior of ovarian cancer cells.
- **Nude mouse xenograft tumor experiment**: Verify the effect of exosomal miR - 98 - 5p on cisplatin resistance in vivo.

### Main Results
- **CDKN1A is highly expressed in cisplatin - sensitive ovarian cancer cell lines**. Silencing CDKN1A significantly promotes cell proliferation and cell cycle entry, but reduces cell apoptosis.
- **miR - 98 - 5p targets CDKN1A** and inhibits its expression.
- **Exosomal miR - 98 - 5p derived from CAFs increases the proliferation and cell cycle entry of ovarian cancer cells**, but inhibits cell apoptosis.
- **Exosomal miR - 98 - 5p promotes cisplatin resistance** and down - regulates CDKN1A expression in nude mice.

### Conclusion
In conclusion, exosomes derived from CAFs carry over - expressed miR - 98 - 5p, which promotes cisplatin resistance in ovarian cancer by down - regulating CDKN1A. This finding provides new potential targets and treatment strategies for overcoming cisplatin resistance in ovarian cancer.